Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys, Inc. reported that Chief Revenue Officer Michael Ellow received a grant of 24,286 restricted stock units on December 12, 2025. Each unit represents the right to receive one share of Synopsys common stock for no cash payment.
The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on June 15, 2026, with the remaining units vesting in five equal semi-annual installments through December 15, 2028, subject to Mr. Ellow’s continued service.
Synopsys, Inc. (SNPS) filed an initial ownership report for its Chief Revenue Officer. The filing states that, as of the event date of 11/20/2025, the reporting officer does not beneficially own any Synopsys securities, either non-derivative or derivative. The form is filed by one reporting person and confirms their executive role and current lack of reportable equity holdings in the company.
Synopsys (SNPS) announced a restructuring plan tied to its ANSYS integration, calling for the termination of approximately 10% of its workforce as of fiscal 2025 year-end. The company expects to recognize pre-tax GAAP charges of $300 million to $350 million for severance, one-time termination benefits, and costs such as certain site closures under its global site strategy.
Synopsys plans for a majority of the workforce reductions in fiscal year 2026 and aims to substantially complete the plan by the end of fiscal year 2027, subject to local law and consultation requirements. Management frames the move as a way to invest in key growth opportunities and drive efficiencies following the ANSYS acquisition. Forward-looking statements note potential changes in the scope, timing, and cost of the actions.
Synopsys, Inc. announced that Chief Revenue Officer Rick Mahoney will no longer serve in the role, effective immediately. The company said it is in advanced stages of its search and expects to announce a replacement shortly.
Synopsys reaffirmed its financial targets for the fourth quarter and full fiscal year 2025 and plans to discuss results on its earnings call on December 10, 2025. The update was provided under Item 7.01 and is not deemed filed under the Exchange Act.
Sudhindra Kankanwadi, Chief Accounting Officer of Synopsys, reported option exercises and share sales in two transactions on September 19 and September 22, 2025. On September 19 he exercised 6,000 non-qualified stock options with an exercise price of $89.76 and sold 6,000 shares (sale price listed as $482). On September 22 he exercised 9,873 options at $89.76 and sold 9,873 shares at a weighted average reported sale price in the filing of $500.90 to $501.04. Following these reported transactions the filing shows he beneficially owns 20,520 shares of Synopsys common stock. The form was signed by POA Liz Ramirez for Mr. Kankanwadi on September 23, 2025.
Sudhindra Kankanwadi, Chief Accounting Officer of Synopsys, reported option exercises and share sales in two transactions on September 19 and September 22, 2025. On September 19 he exercised 6,000 non-qualified stock options with an exercise price of $89.76 and sold 6,000 shares (sale price listed as $482). On September 22 he exercised 9,873 options at $89.76 and sold 9,873 shares at a weighted average reported sale price in the filing of $500.90 to $501.04. Following these reported transactions the filing shows he beneficially owns 20,520 shares of Synopsys common stock. The form was signed by POA Liz Ramirez for Mr. Kankanwadi on September 23, 2025.
Form 144 filed for Synopsys, Inc. (SNPS) reports a proposed sale of 9,873 common shares to be executed through Morgan Stanley Smith Barney on 09/22/2025, with an aggregate market value of $4,945,407.42. The filer acquired these shares on 09/22/2025 by exercising stock options and paid in cash. The filing also discloses a prior sale by Sudhindra Kankanwadi of 6,000 shares on 09/19/2025 for $2,892,000.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for Synopsys, Inc. (SNPS) reports a proposed sale of 9,873 common shares to be executed through Morgan Stanley Smith Barney on 09/22/2025, with an aggregate market value of $4,945,407.42. The filer acquired these shares on 09/22/2025 by exercising stock options and paid in cash. The filing also discloses a prior sale by Sudhindra Kankanwadi of 6,000 shares on 09/19/2025 for $2,892,000.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Synopsys, Inc. (SNPS) notice reports a proposed sale under Rule 144 of 6,000 common shares via Morgan Stanley Smith Barney LLC on 09/19/2025 with an aggregate market value of $2,892,000.00. The shares were acquired the same day through a stock option exercise and paid in cash. The filing states there were no other securities sold by the reporting person in the prior three months and includes the standard representation that the seller has no undisclosed material adverse information about the issuer.
Synopsys, Inc. (SNPS) notice reports a proposed sale under Rule 144 of 6,000 common shares via Morgan Stanley Smith Barney LLC on 09/19/2025 with an aggregate market value of $2,892,000.00. The shares were acquired the same day through a stock option exercise and paid in cash. The filing states there were no other securities sold by the reporting person in the prior three months and includes the standard representation that the seller has no undisclosed material adverse information about the issuer.
Synopsys, Inc. filed an amendment to a current report to expand its prior disclosure about board changes. The filing confirms that on July 17, 2025, the board appointed Mr. Vijayaraghavan as a director. It further clarifies that, effective September 17, 2025, he was also appointed to the Corporate Governance and Nominating Committee of the board. No other aspects of the earlier report were revised, so this update is limited to committee responsibilities for the new director.
Synopsys, Inc. filed an amendment to a current report to expand its prior disclosure about board changes. The filing confirms that on July 17, 2025, the board appointed Mr. Vijayaraghavan as a director. It further clarifies that, effective September 17, 2025, he was also appointed to the Corporate Governance and Nominating Committee of the board. No other aspects of the earlier report were revised, so this update is limited to committee responsibilities for the new director.
Synopsys, Inc. filed an amendment to a current report to expand its prior disclosure about board changes. The filing confirms that on July 17, 2025, the board appointed Mr. Vijayaraghavan as a director. It further clarifies that, effective September 17, 2025, he was also appointed to the Corporate Governance and Nominating Committee of the board. No other aspects of the earlier report were revised, so this update is limited to committee responsibilities for the new director.
Robert G. Painter, a director of Synopsys, acquired 350 shares of Synopsys Inc. common stock on 09/11/2025 at a reported price of $425.4397 per share. After the purchase, Mr. Painter beneficially owned 2,291 shares directly.
The Form 4 was filed as a single reporting person filing and the form bears a signature by power of attorney, Liz Ramirez, on behalf of Mr. Painter dated 09/15/2025. No derivative transactions or additional explanatory text are included.
Synopsys reported a transaction-heavy quarter driven by the completed acquisition of Ansys and related financing. The company closed the Ansys Merger on July 17, 2025 and included Ansys results prospectively. To fund the cash portion of the merger, Synopsys issued Senior Notes with approximately $9.9 billion net proceeds and borrowed the full $4.3 billion under a Term Loan. Synopsys recognized a $860.5 million pre-tax gain (net of adjustments) from the prior sale of its Software Integrity business and has $10.1 billion of contracted but unsatisfied performance obligations (backlog) as of July 31, 2025. The company recorded an unrealized $121.6 million loss from terminated interest rate locks that is being amortized to interest expense, suspended its $1.5 billion repurchase program with $194.3 million remaining, and reported material operational headwinds in its Design IP segment related to China export control developments.